Latest News
Billionaire Seth Klarman Sold 64% of Baupost's Stake in Alphabet and Is Piling Into This Historically Cheap and Under-the-Radar Drugmaker
Ardent value investor Seth Klarman is swapping out shares of search engine juggernaut Alphabet for a relatively unknown pharmaceutical stock that has a forward price-to-earnings ratio of 5!
The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.25%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.77%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.79%. Stock indexes settled mixed on Thursday, with the Dow Jones Industrials posting a 4-week...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.71%. Stock indexes today are mixed, after the S&P 500 and Nasdaq 100 climbed to...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. Stock indexes today are mildly higher, with the S&P 500 and Nasdaq 100 climbing...
3 No-Brainer Stocks to Buy With $300 Right Now
A modest amount of money can go a long way on Wall Street when it's put to work in time-tested businesses with well-defined catalysts.
4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The Nasdaq Composite is the only major stock index that hasn't put the 2022 bear market in the rearview mirror. For patient investors, it means bargains still abound.
4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The growth-fueled Nasdaq Composite remains nearly 6% below its all-time high, which means amazing deals can still be found.
2 Incredible Growth Stocks That Are Screaming Buys for 2024
These healthcare businesses are compelling buys for very different reasons.
4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
The growth-fueled Nasdaq Composite remains 7% below its all-time high, which means bargains can still be found.
3 No-Brainer Stocks to Buy With $500 Right Now
You don't need a mountain of cash to build wealth on Wall Street.
3 Biotech Stocks That Could Be Millionaire Makers
Many biotech stocks offer exciting long-term growth prospects.
3 No-Brainer Stocks to Buy With $200 Right Now
A modest amount of money can go a long way when it's invested in inexpensive, game-changing businesses.
What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -1.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.50%. Stocks on Friday retreated, with the S&P 500,...
What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.87%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.46%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.19%. Stocks this morning are moderately lower, with the S&P...
Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.38%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.45%, both at 2-week lows. Stock index futures this morning are moderately lower on concern the conflict between Israel and Hamas may widen to a regional conflict....
Jazz Pharmaceuticals to Present Latest Advancements in Sleep Medicine at World Sleep 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep...
Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with partners, will present six abstracts including data from...
2 Top Biotech Stocks to Buy in October
Growth catalysts lie ahead for both of these players.
5 Genius Safe Stocks to Buy for the 4th Quarter of 2023
These highly profitable, time-tested companies can deliver for their shareholders in any economic climate.
4 Perfect Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
An 18% decline in the Nasdaq Composite from its all-time high means bargains still abound.
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty
/PRNewswire/ -- USA News Group - Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer...
Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Commission (EC) has granted marketing authorization for Enrylaze®...
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare...
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
NetworkNewsWire Editorial Coverage : More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare...
Pioneering Cancer Treatments Show Promising Progress Despite Fiscal Challenges
USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal, optimism in the battle against cancer persists, thanks in large part to the audacious “Cancer Moonshot” initiative. This...